Skip to main content
Some text as placeholder. In real life you can have the elements you have chosen. Like, text, images, lists, etc.
What are you looking for?

Are Personal HCPs the Link to More Fully Enrolled and Diverse Clinical Trials?

In April of 2022, the FDA issued its 9th guidance to combat the negative impacts of demographically-biased trials. But how can the industry ensure that this guidance achieves the results that all involved want and need? What can stakeholders do that has not already been done for more fully enrolled – and equitable – clinical trials?

To answer that question, Syneos Health experts break down how marketers must pay attention to the stakeholders at the core of every clinical trial: patients and caregivers and their existing relationships with healthcare providers.

Download the article below

To download the free whitepaper, fill out the form below:

Interested in Syneos Health?